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This issue of Seminars in Immunopathology is devoted to
the topic of inflammatory and autoimmune diseases of the
central nervous system (CNS). As editors, we are gratified
that a panel of distinguished expert colleagues kindly
accepted our invitation to contribute an article, each
covering an essential aspect of the overall topic. Taken
together, the articles cover a broad spectrum of neuro-
immunology and neuroinflammation.
In the first article, Wei Hu and Claudia F. Lucchinetti
discuss the neuropathological spectrum of CNS inflamma-
tory demyelinating diseases. The authors emphasize the
emerging heterogeneity of these disorders, with multiple
sclerosis (MS) being the most common but by no means
only the disease in this category. They also provide us with
an update on the exciting new developments in neuro-
myelitis optica, a disorder which has recently been
redefined by the presence of autoantibodies against the
aquaporin-4 water channel. The second article, authored by
Monika Bradl and Hans Lassmann, focuses on progressive
MS, the “step-child of MS therapeutics.” The authors demon-
strate that also in progressive MS, inflammation is the driving
force for CNS injury, and they present plausible explanations
why it is so difficult to treat progressive forms of MS.
In the third article, Klaus Dornmair, Edgar Meinl, and
Reinhard Hohlfeld discuss novel approaches for identifying
target antigens of autoreactive human B and T cells.
Whereas many antigens have shown encephalitogenic
properties in animal models, it has been difficult to identify
the target antigens of pathogenic immune reactions in
human diseases. New techniques allow the isolation of
individual tissue-infiltrating B and T cells, so that their
clonotypical antigen-specific receptors can be reconstructed
from single cells. The reconstructed antigen-specific recep-
tors are then expressed in living cell lines, which can be
used in the search for unknown target antigens.
In the next article, merits and shortcomings of animal
models of MS are critically discussed in detail by Bettina
Schreiner, Frank L. Heppner, and Burkhard Becher. Various
experimental autoimmune encephalomyelitis (EAE) models
have greatly contributed to our current understanding of
MS pathogenesis, albeit it has been difficult to bridge the
gap between EAE and MS research. The most recent
generation of EAE models make extensive use of genetic
engineering methods, such as transgenic and knockout
techniques, allowing detailed studies of various aspects of
immunopathogenesis. Special emphasis is placed on mod-
els elucidating the role of newly emerging subsets of
autoimmune T cells, including TH17 cells and regulatory T
cells (Treg).
Britta Engelhardt and Lydia Sorokin provide firsthand
insight into the intricate workings of one of the most
essential areas of neuroinflammation, the blood–brain and
blood–cerebrospinal fluid barriers. The authors discuss the
structure of the blood–brain barrier under physiological
conditions and emphasize how changes of its function
become crucially important in pathological conditions. The
blood–brain barrier is also a key site for therapeutic
intervention, as recently evidenced by the approval of the
therapeutic monoclonal antibody natalizumab, which is
directed against alpha-4-beta-1-integrin and inhibits the
influx of autoaggressive T cells into the CNS.
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Lisa Walter and Harald Neumann then authoritatively
discuss the role of microglia in neuronal degeneration and
regeneration, emphasizing that microglia has a double-sided
nature because it can both mediate neuroprotection and
neurotoxicity.
Neil J. Scolding provides an overview on CNS vascu-
litis, describing different subtypes of vasculitis and discus-
sing diagnostic and therapeutic approaches.
In the last article of this issue, Jan Bauer and
Christian G. Bien consider different kinds of encephalitis
associated with epilepsy: Rasmussen encephalitis, para-
neoplastic encephalitis and certain forms of nonparaneo-
plastic encephalitis.
We hope that the readers are as excited as we are about
this unique collection of articles covering a wide spectrum
of current basic and clinical neuroimmunology. We would
like to thank all authors and co-authors for their excellent
contributions and, last but not least, would like to express
our gratitude to the editorial staff of Springer for compe-
tently supporting us in preparing this issue.
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